FIRRM and adrenal cortex carcinoma: Furthermore, DFS analysis showed that high C1ORF112 expression was a marker for poor outcome for patients with ACC (p = 4.3 × 10–3), KIRP (p = 6.6 × 10–3), LGG (p = 1.4 × 10–6), MESO (p = 3.6 × 10–2), PRAD (p = 3.2 × 10–2), and SARC (p = 1.4 × 10–2) (Figures 3A–G).